PIMA110245

CD52 Monoclonal Antibody (HI186), APC, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA110245-Each-of-1 In Stock ₹ 38,359.00

PIMA110245 - Each of 1

₹ 38,359.00

In Stock

Quantity

1

Base Price: ₹ 38,359.00

GST (18%): ₹ 6,904.62

Total Price: ₹ 45,263.62

Antigen

CD52

Classification

Monoclonal

Conjugate

APC

Gene

CD52

Gene Alias

AI463198; B7; B7-Ag; cambridge pathology 1 antigen; CAMPATH-1; CAMPATH-1 antigen; Cd52; CD52 antigen; CD52 antigen (CAMPATH-1 antigen); CD52 molecule; CDW52; CDW52 antigen (CAMPATH-1 antigen); CLS1; Epididymal secretory protein E5; epididymis secretory sperm binding protein Li 171mP; he5; HEL-S-171mP; human epididymis-specific protein 5; Lymphocyte differentiation antigen B7; Mb7

Host Species

Mouse

Purification Method

Size-exclusion chromatography

Regulatory Status

RUO

Gene ID (Entrez)

1043

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

HI186

Formulation

PBS with 0.2% BSA and 15mM sodium azide; pH 7.4

Gene Accession No.

P31358

Gene Symbols

CD52

Immunogen

Human tonsil

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b

Related Products

Img

Novus Biologicals

NB287164

--

Img

Novus Biologicals

NB383282

--

Img

Novus Biologicals

NB379342

--

Img

Novus Biologicals

NB453514

--

Img

Novus Biologicals

NB359387

--

Img

Novus Biologicals

NB359385

--

Img

Thermo Scientific

PIMA110247

--

Img

Thermo Scientific

PIMA110307

--

Description

  • CD52, also known as CAMPATH-1 antigen, is a glycoprotein that is expressed on the surface of various immune cells, including T and B lymphocytes, natural killer cells, and monocytes
  • It is involved in the regulation of immune responses and is being studied as a potential therapeutic target in various diseases, including multiple sclerosis, chronic lymphocytic leukemia, and autoimmune disorders
  • CD52 is the target of alemtuzumab, a monoclonal antibody that is used to treat these conditions by depleting immune cells that express CD52.